Source: World Journal of Hepatology. Unidade: IFSC
Subjects: OBESIDADE, FÍGADO GORDUROSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMORIM, Viviane Brandão et al. Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?. World Journal of Hepatology, v. 12, n. 9, p. 661-671, 2020Tradução . . Disponível em: https://doi.org/10.4254/wjh.v12.i9.661. Acesso em: 07 out. 2024.APA
Amorim, V. B., Parente, D. B., Paiva, F. F., Oliveira Neto, J. A., Miranda, A. A., Moreira, C. C., et al. (2020). Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? World Journal of Hepatology, 12( 9), 661-671. doi:10.4254/wjh.v12.i9.661NLM
Amorim VB, Parente DB, Paiva FF, Oliveira Neto JA, Miranda AA, Moreira CC, Fernandes FF, Campos CFF, Leite NC, Perez R de M, Rodrigues RS. Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? [Internet]. World Journal of Hepatology. 2020 ; 12( 9): 661-671.[citado 2024 out. 07 ] Available from: https://doi.org/10.4254/wjh.v12.i9.661Vancouver
Amorim VB, Parente DB, Paiva FF, Oliveira Neto JA, Miranda AA, Moreira CC, Fernandes FF, Campos CFF, Leite NC, Perez R de M, Rodrigues RS. Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? [Internet]. World Journal of Hepatology. 2020 ; 12( 9): 661-671.[citado 2024 out. 07 ] Available from: https://doi.org/10.4254/wjh.v12.i9.661